Human Insulin (Regular / NPH)
Humulin / Novolin
Insulin is the hormone the pancreas releases after eating to move glucose out of the bloodstream and into cells for energy and storage. It is a small protein of 51 amino acids arranged as two chains — an A-chain of 21 residues and a B-chain of 30 — held together by disulfide bridges. Discovered in 1921–22, purified from animal pancreas for decades, and since the 1980s produced as recombinant "human" insulin (an exact copy of the human sequence made in bacteria or yeast), insulin is one of medicine's most important and life-saving drugs and a WHO Essential Medicine. Human insulin is supplied in two classic forms distinguished by how fast and how long they act. Regular (soluble) insulin is short-acting: injected under the skin it begins working in about 30 minutes and covers a meal over several hours, and it is the form given intravenously in hospitals for emergencies such as diabetic ketoacidosis. NPH (isophane) insulin is intermediate-acting: it is Regular insulin complexed with protamine so it forms a cloudy suspension that dissolves slowly, giving a longer, peaked action used as a basal (background) insulin. Many people combine the two, and premixed formulations exist. Modern rapid-acting and long-acting analog insulins (lispro, aspart, glargine, degludec and others) were engineered to improve on human insulin's timing, but Regular and NPH remain widely used worldwide, are far less expensive, and are entirely adequate for many patients. All insulins share the same fundamental risk — hypoglycemia (blood sugar too low) — and require dose matching to food, activity, and glucose monitoring. Insulin is a prescription hormone used under medical guidance in type 1 diabetes (where it is essential to life), in many people with type 2 diabetes, and in other conditions; it is not a performance or wellness product, and dosing errors can be dangerous.
Specifications
| Dose Range | U-100 standard (U-500 concentrated Regular exists) |
| Origin / Manufacturer | Recombinant human sequence (E. coli or yeast) |
| Regulatory Status | FDA-approvedEMA-approvedWHO Essential Medicine |
| Active Components | Human insulin (rDNA origin) |
| Storage | Refrigerate unopened; in-use vials/pens per label |
| Form Factor | Subcutaneous injection (vial/pen); Regular also IV |
Frequently Asked Questions
Reviewed by
Clinical Research Review Board
Pharmacology & Endocrinology Review
All clinical claims cross-checked against primary sources. Read our editorial policy →
Related Peptides
Glucagon
GlucaGen / Baqsimi / Gvoke
Insulin's counter-regulatory partner: a 29–amino-acid pancreatic hormone that raises blood glucose by mobilizing the liver's stored sugar. As a medicine it is the emergency rescue treatment for severe hypoglycemia.
Insulin Aspart
NovoLog / NovoRapid / Fiasp
A rapid-acting analog insulin: replacing one B-chain amino acid with aspartic acid reduces self-clumping for fast mealtime action. An ultra-rapid version (Fiasp) is absorbed even more quickly.
Insulin Degludec
Tresiba
An ultra-long-acting basal insulin: a fatty-acid tail makes it form long chains of multihexamers under the skin that release insulin very slowly, giving an exceptionally flat profile lasting well beyond 24 hours with flexible dosing timing.
Insulin Glargine
Lantus / Toujeo / Basaglar
A long-acting basal analog insulin engineered to precipitate under the skin and release slowly, giving roughly 24-hour, relatively flat background glucose coverage from a once-daily injection.
Insulin Lispro
Humalog / Admelog / Lyumjev
A rapid-acting analog insulin: swapping two B-chain amino acids stops the molecules from clumping, so it is absorbed and acts faster than human Regular insulin — designed to be taken right at mealtimes.